About Glantreo

Founded in 2004, Glantreo has its principal business offices in the Rubicon Center in Cork. The company has Laboratory space in UCC's Environmental Research Institute, and utilizes several powerful equipment sets in University College Cork. It was originally founded by Prof. Michael Morris and Dr. Justin Holmes as a means to commercialize potential IP that they generated. It was subsequently joined by Dr. John Hanrahan as CTO to enable the company to grow and sustain its products and services to the Marketplace.

Glantreo has already made something of a name for itself among the blue chip and Fortune 500 Pharmaceutical, Medical Device and Biotech companies in the greater Cork area, and numbers many of these companies among its clients.

Glantreo is also fortunate to have a very experienced Board, who are heavily involved in all aspects of the company's activities, and a prestigious selection of Scientific Advisors.

Our Executive Board

Dr. Jim McGrath - Chairman

Dr. McGrath has been a member of the Board since November of 2007. His first position after completing his Post Graduate was as a Senior Research Scientist in a Government Funded Program for Advanced Technology, Power Electronics Ireland. In this role, Dr. McGrath managed and completed projects for Multinational Corporations in the Tyndall Institute. The projects involved Product Development, Technology Transfer and Development of Manufacturing Systems. After this position, Dr. McGrath joined Analog Devices where he held a Senior Project Management Position. In this role within the Semiconductor Industry, he was responsible for sustaining large sections of the Manufacturing Processes, Transfer and Scale up of new Technologies, and support of New Product Development. Directly after Analog Devices he joined Kinematik (a software company, supporting the Life Sciences Market), as the Vice President for Implementation and Support, where he was responsible for the companies Global Operations and as an executive in the Business had the task of growing and scaling the business globally. This was done successfully. He then joined the Executive Team of Pharma-BioServ, as the European General Manager.

Dr. John Hanrahan - Chief Technology Officer

Dr John Hanrahan (CTO) Glantreo Ltd. My current roles and responsibilities within the company include the management of the day to day operations of the company; this includes working across all 3 business units as outlined in the business plan. I have been instrumental in growing the analysis service unit of the company. My present position's responsibilities have include completion of sales contracts, IP evaluations, R&D, tech transfer, process development, contract research proposals, confidentiality agreements and product/service presentations. I have also been instrumental in Patent Application and Validation of our new products and I am currently involved in the licensing of one of our product to a large multi-national. Previous to this position I was a senior post doc with the Morris research group in UCC.

Professor Mick Morris

Educated in Liverpool University, Prof. Morris' first postdoctoral position was in Imperial College London, 1982-1985, where he won the RSC C. R. Burch prize for surface chemistry. Subsequently he held Lecturing positions at Strathclyde University and the University of Wales in Cardiff, before working for ICI plc for 5 years. Since then he has lectured at University College Cork, earning an Associate Professorship and forming the Dimensional Materials research group. Under his direction, this group has become one of the most important research groups in the UCC Chemistry department; its work has been supported by the HEA (PRTL and Large Equipment Grant), EU and Enterprise Ireland and SFI (CRANN and PI award) and Intel, with income of over 5M Euro in the last 8 years. The group also has a very strong relationship with Intel US, from which it has received two corporate research awards. In addition, Glantreo Ltd, a spin-out company, has been set up to commercialize the work of the Dimensional Materials group. Current research interests are associated with the synthesis of inorganic solids - particularly complex oxides - and their structural and compositional characterisation. Many of these materials are prepared as thin films and as nanostructured solids so that structure and properties can be controlled. Some of this work relates to developing routes to lanthanide containing oxides as potential electric and dielectric materials. We have also used structured Mesporous materials as low-k dielectrics in collaboration with Intel. We have also pioneered means by which Mesporous materials can act as templates for the growth of quantum-confined semiconductor, oxide and metallic materials in the form of nanowires and nanoparticles.

Our Scientific Advisory Board

Dr Justin Holmes

Dr Holmes is a Senior Lecturer in Physical/Materials Chemistry at University College Cork (UCC), Ireland. His first postdoctoral position was at the University of East Anglia, England, under the supervision of Professor B.H. Robinson and Dr D. C. Steytler, where he developed surfactants to stabilise water droplets in supercritical carbon dioxide and demonstrated the viability of these systems for enzyme-catalysed reactions and nanoparticle synthesis. In 1998, Dr Holmes took up a postdoctoral position in the Department of Chemical Engineering at the University of Texas at Austin, U.S.A., under the supervision of Professors K.P. Johnston and B.A. Korgel, where he researched the formation, stabilisation and assembly of nanoscale materials in supercritical fluids. Since joining the Chemistry Department at UCC in October 1999, Dr Holmes has established an active research group in the synthesis and assembly of nanoscale materials for electronic, magnetic, environmental and biological applications. Dr Holmes is a Principal Investigator within the Centre for Adaptive Nanostructures and Nanodevices (CRANN) where he is leading a project to construct new nanowire-based electronic devices. He is also a Principal Investigator and Group Leader at the Tyndall National Institute in Cork, investigating nanoscale magnetic materials, and co-founder of the UCC spin-out company Glantreo Ltd.

Dr David Corr

A pioneer in nanomaterial science and nanotechnology with deep commercial experience, David is responsible for NTERA's commercial operations, as well as the operation of the Dublin design center. David co-founded NTERA while working on his PhD thesis at the University College Dublin. David helped secure over $30 million in private equity investment in NTERA and was responsible for developing NTERA's academic and commercial relationships. Under his leadership, NTERA successfully transitioned from academic to commercial environment, including performing fundamental research breakthroughs while leveraging multimillion dollar grants from the European Union. David led the effort to develop the technology transfer processes for NTERA's technology, including successful transformation of an existing LCD manufacturing facility in Taiwan. Earlier, David worked as an engineering researcher with Wyeth Medica Ireland, responsible for technology transfer and new product introductions. David holds bachelor's degrees in chemistry, mathematics and biology, a master's degree in business administration and a PhD in chemistry, University College Dublin. He is a widely recognized industry commentator (e.g., Asia Display Conference, Symposium for Information Displays, European Business Summit, Annual BCC Conference on Nanoparticles, numerous peer-reviewed publications) and inventor (10 patent families in the area of Nanoparticle electrochromics).